{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T04:34:25Z","timestamp":1775622865423,"version":"3.50.1"},"reference-count":24,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T00:00:00Z","timestamp":1750896000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Bisphosphonates (BP) like zoledronic acid (ZA) and alendronic acid (AA) are used for osteoporosis (OP) or other bone-related conditions as well as to prevent the spread of metastases and in rheumatoid arthritis treatment. However, they have been associated with an increased risk of osteonecrosis of the jaw (ONJ). This systematic review aimed to assess the incidence and risk of ONJ in osteoporotic patients treated with ZA or AA and evaluate the impact of treatment duration. Material and Methods: The systematic literature review was conducted following PRISMA guidelines. The keywords \u201cZoledronic acid,\u201d \u201cAlendronic acid,\u201d \u201cOsteoporosis,\u201d and \u201cOsteonecrosis\u201d were searched in PubMed and ScienceDirect databases. Selection criteria included studies on humans written in English, published from 2014. The systematic review protocol was registered in the PROSPERO register under the following number: CRD42024587046. Results: A total of 7 studies with 98,717 osteoporotic patients met the criteria, showing a higher ONJ incidence with ZA than AA. Six studies linked longer BP use to increased ONJ risk, which quadrupled after 5 years of AA use. A positive correlation was found between BP use (\u22653 years) and ONJ in OP patients, primarily affecting females over 60. ONJ appeared after 1 year with AA, increasing over time, while ZA-related ONJ emerged as early as 5 months with a higher overall incidence. Conclusions: ZA poses a higher ONJ risk and incidence and earlier onset than AA, occurring within 5 months versus 1 year for AA. These findings emphasize the need for careful monitoring, especially in long-term BP therapy with additional risk factors.<\/jats:p>","DOI":"10.3390\/medicina61071159","type":"journal-article","created":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T11:15:23Z","timestamp":1750936523000},"page":"1159","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Risk of Osteonecrosis of the Jaw in Patients Treated with Zoledronic or Alendronic Acid: A Systematic Review"],"prefix":"10.3390","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-2244-1964","authenticated-orcid":false,"given":"Aine","family":"Jakonyte","sequence":"first","affiliation":[{"name":"Department of Odontology, Lithuanian University of Health Sciences (LSMU), LT-50161 Kaunas, Lithuania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Egle","family":"Gustainyte","sequence":"additional","affiliation":[{"name":"Department of Odontology, Lithuanian University of Health Sciences (LSMU), LT-50161 Kaunas, Lithuania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9114-7416","authenticated-orcid":false,"given":"Zygimantas","family":"Petronis","sequence":"additional","affiliation":[{"name":"Department of Maxillofacial Surgery, Faculty of Odontology, Medical Academy, Lithuanian University of Health Sciences (LSMU), LT-50161 Kaunas, Lithuania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-0771-662X","authenticated-orcid":false,"given":"Aviad","family":"Hafizov","sequence":"additional","affiliation":[{"name":"Department of Odontology, Lithuanian University of Health Sciences (LSMU), LT-50161 Kaunas, Lithuania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Audra","family":"Janovskiene","sequence":"additional","affiliation":[{"name":"Department of Maxillofacial Surgery, Faculty of Odontology, Medical Academy, Lithuanian University of Health Sciences (LSMU), LT-50161 Kaunas, Lithuania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8025-9626","authenticated-orcid":false,"given":"Dainius","family":"Razukevicius","sequence":"additional","affiliation":[{"name":"Department of Maxillofacial Surgery, Faculty of Odontology, Medical Academy, Lithuanian University of Health Sciences (LSMU), LT-50161 Kaunas, Lithuania"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,6,26]]},"reference":[{"key":"ref_1","first-page":"e49399","article-title":"Unraveling the Relationship Between Osteoporosis, Treatment Modalities, and Oral Health: A Comprehensive Review","volume":"15","author":"Sharma","year":"2023","journal-title":"Cureus"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"46","DOI":"10.5152\/eurjrheum.2016.048","article-title":"An overview and management of osteoporosis","volume":"4","author":"Sozen","year":"2017","journal-title":"Eur. J. Rheumatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1172\/JCI110667","article-title":"Changes in Bone Mineral Density of the Proximal Femur and Spine with Aging","volume":"70","author":"Riggs","year":"1982","journal-title":"J. Clin. Investig."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1007\/s00198-014-2655-z","article-title":"The clinical diagnosis of osteoporosis: A position statement from the National Bone Health Alliance Working Group","volume":"25","author":"Siris","year":"2014","journal-title":"Osteoporos. Int."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Liu, F., Wang, X., He, Y., Han, R., Wang, T., and Guo, Y. (2024). Jaw osteoporosis: Challenges to oral health and emerging perspectives of treatment. Biomed. Pharmacother., 177.","DOI":"10.1016\/j.biopha.2024.116995"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"115412","DOI":"10.1016\/j.bone.2020.115412","article-title":"Alendronate or Zoledronic acid do not impair wound healing after tooth extraction in postmenopausal women with osteoporosis","volume":"137","author":"Lesclous","year":"2020","journal-title":"Bone"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.bone.2011.04.022","article-title":"Bisphosphonates: The first 40 years","volume":"49","author":"Russell","year":"2011","journal-title":"Bone"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.5037\/jomr.2023.14403","article-title":"Assessment Results of Dental Students\u2019 Knowledge about Bisphosphonates and Bisphosphonate-Related Osteonecrosis of the Jaw","volume":"14","author":"Sereikaite","year":"2023","journal-title":"J. Oral Maxillofac. Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"100259","DOI":"10.1016\/j.jbo.2019.100259","article-title":"Atypical femoral fractures from bisphosphonate in cancer patients\u2014Review","volume":"18","author":"Lockwood","year":"2019","journal-title":"J. Bone Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement","volume":"4","author":"Moher","year":"2015","journal-title":"Syst. Rev."},{"key":"ref_11","first-page":"7","article-title":"Methodological quality (risk of bias) assessment tools for primary and secondary medical studies: What are they and which is better?","volume":"7","author":"Ma","year":"2020","journal-title":"Mil. Med. Res."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Kim, Y., Tian, Y., Yang, J., Huser, V., Jin, P., Lambert, C.G., Park, H., You, S.C., Park, R.W., and Rijnbeek, P.R. (2020). Comparative safety and effectiveness of alendronate versus raloxifene in women with osteoporosis. Sci. Rep., 10, Available online: https:\/\/www.nature.com\/articles\/s41598-020-68037-8.","DOI":"10.1038\/s41598-020-68037-8"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.bjoms.2015.10.036","article-title":"Epidemiological study of alendronate-related osteonecrosis of the jaw in the southeast of Scotland","volume":"54","author":"Sammut","year":"2016","journal-title":"Br. J. Oral Maxillofac. Surg."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/odi.14003","article-title":"Frequency of osteonecrosis in bisphosphonate users submitted to dental procedures: A systematic review","volume":"29","author":"Martins","year":"2023","journal-title":"Oral Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s00784-018-2505-z","article-title":"Influence of pH on osteoclasts treated with zoledronate and alendronate","volume":"23","author":"Arnett","year":"2019","journal-title":"Clin. Oral Investig."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1007\/s00198-017-4132-y","article-title":"Surgically treated osteonecrosis and osteomyelitis of the jaw and oral cavity in patients highly adherent to alendronate treatment: A nationwide user-only cohort study including over 60,000 alendronate users","volume":"28","author":"Eiken","year":"2017","journal-title":"Osteoporos. Int."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1016\/j.joms.2021.07.029","article-title":"Recurrence-Related Factors of Medication-Related Osteonecrosis of the Jaw: A Five-Year Experience","volume":"79","author":"Chen","year":"2021","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/odi.12632","article-title":"Time to onset of bisphosphonate-related osteonecrosis of the jaws: A multicentre retrospective cohort study","volume":"23","author":"Fung","year":"2017","journal-title":"Oral Dis."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Chiu, W.-Y., Yang, W.-S., Chien, J.-Y., Lee, J.-J., and Tsai, K.-S. (2018). The influence of alendronate and tooth extraction on the incidence of osteonecrosis of the jaw among osteoporotic subjects. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0196419"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1210\/jc.2013-4119","article-title":"The Risk of Osteonecrosis of the Jaws in Taiwanese Osteoporotic Patients Treated With Oral Alendronate or Raloxifene","volume":"99","author":"Chiu","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"105599","DOI":"10.1016\/j.jbspin.2023.105599","article-title":"Zoledronate and osteonecrosis of the jaw in osteoporosis: Incidence and risk factors. Analysis of the French Pharmacovigilance Database","volume":"90","author":"Amigues","year":"2023","journal-title":"Jt. Bone Spine"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1007\/s00198-014-2624-6","article-title":"Incidence and risk of osteonecrosis of the jaw among the Taiwan osteoporosis population","volume":"25","author":"Lin","year":"2014","journal-title":"Osteoporos. Int."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1056\/NEJMoa1708322","article-title":"Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis","volume":"377","author":"Saag","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.otorri.2014.06.003","article-title":"Epidemiolog\u00eda, farmacolog\u00eda y caracterizaci\u00f3n cl\u00ednica de la osteonecrosis de los maxilares. Un estudio retrospectivo de 70 casos","volume":"66","author":"Pelaz","year":"2015","journal-title":"Acta Otorrinolaringol. Espa\u00f1ola"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/7\/1159\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:59:12Z","timestamp":1760032752000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/7\/1159"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,26]]},"references-count":24,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["medicina61071159"],"URL":"https:\/\/doi.org\/10.3390\/medicina61071159","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,26]]}}}